RONCHINI, CHIARA
RONCHINI, CHIARA
DIPARTIMENTO DI SCIENZE BIOMOLECOLARI E BIOTECNOLOGIE (attivo dal 01/06/2003 al 27/04/2012)
High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients
2024 C. Ronchini, C. Caprioli, G. Tunzi, F.F. D'Amico, E. Colombo, M. Giani, G. Foti, D. Conconi, M. Lavitrano, R. Passerini, L. Pase, S. Capizzi, F. Mastrilli, M. Alcalay, R. Orecchia, G. Natoli, P.G. Pelicci
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
2023 S. Raimondi, S. Gandini, G.H. Rubio Quintanares, A. Abecasis, P.L. Lopalco, O. D'Ecclesiis, S. Chiocca, E. Tomezzoli, I. Cutica, D. Mazzoni, N. Amparo, M. Pingarilho, D. Carmagnola, C. Dellavia, G. Zuccotti, C. Ronchini, F. Bellerba, F. Dewald, R. Kaiser, F. Incardona
High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias
2023 A. Magi, G. Mattei, A. Mingrino, C. Caprioli, C. Ronchini, G. Frigè, R. Semeraro, D. Bolognini, A. Rambaldi, A. Candoni, E. Colombo, L. Mazzarella, P.G. Pelicci
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors : a single-center experience
2021 E. Todisco, F. Gigli, M. Mantiero, S. Sammassimo, R. Pastano, C. Ronchini, G. Parma, M.T. Lapresa, A.P. Iori, F. Bertolini, C. Corsini, G. Gregato, C. Poletti, N. Colombo, C. Tarella
Efficacy of venetoclax based salvage chemotherapy followed by “Minimal Residual Disease driven”-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia
2020 E. Todisco, F. Gigli, S. Sammassimo, C. Camisaschi, P. Mancuso, C. Ronchini, S. Ramadan, F. Bertolini, R. Pastano, C. Tarella
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
2018 A. Ghelli Luserna Di Rora, N. Beeharry, E. Imbrogno, A. Ferrari, V. Robustelli, S. Righi, E. Sabattini, M.V. Verga Falzacappa, C. Ronchini, N. Testoni, C. Baldazzi, C. Papayannidis, M.C. Abbenante, G. Marconi, S. Paolini, S. Parisi, C. Sartor, M.C. Fontana, S. De Matteis, I. Iacobucci, P.G. Pelicci, M. Cavo, T.J. Yen, G. Martinelli
PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias
2017 C. Ronchini, A. Brozzi, L. Riva, L. Luzi, A.M. Gruszka, G.E.M. Melloni, E. Scanziani, G. Dharmalingam, M. Mutarelli, V. Belcastro, S. Lavorgna, V. Rossi, O. Spinelli, A. Biondi, A. Rambaldi, F. Lo Coco, D. di Bernardo, P.G. Pelicci
The hidden genomic landscape of acute myeloid leukemia : Subclonal structure revealed by undetected mutations
2015 M. Bodini, C. Ronchini, L. Giacò, A. Russo, G.E..M. Melloni, L. Luzi, D. Sardella, S. Volorio, S.K. Hasan, T. Ottone, S. Lavorgna, F. Lo-Coco, A. Candoni, R. Fanin, E. Toffoletti, I. Iacobucci, G. Martinelli, A. Cignetti, C. Tarella, L. Bernard, P.G. Pelicci, L. Riva
The combination of the PARP inhibitor rucaparib and 5FU is an effective strategy for treating acute leukemias
2015 M.V. Verga Falzacappa, C. Ronchini, M. Faretta, I. Iacobucci, A. Ghelli Luserna Di Rorà, G. Martinelli, L.H. Meyer, K. Debatin, S. Orecchioni, F. Bertolini, P.G. Pelicci
Erratum: Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups
2014 L. Riva, C. Ronchini, M. Bodini, F. Lo-Coco, S. Lavorgna, T. Ottone, G. Martinelli, I. Iacobucci, C. Tarella, A. Cignetti, S. Volorio, L. Bernard, A. Russo, G.E.M. Melloni, L. Luzi, M. Alcalay, G.I. Dellino, P.G. Pelicci